vs

Side-by-side financial comparison of FARMERS NATIONAL BANC CORP (FMNB) and MEDIFAST INC (MED). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $71.5M, roughly 1.1× FARMERS NATIONAL BANC CORP). On growth, FARMERS NATIONAL BANC CORP posted the faster year-over-year revenue change (3.2% vs -36.9%). FARMERS NATIONAL BANC CORP produced more free cash flow last quarter ($52.2M vs $-6.6M). Over the past eight quarters, FARMERS NATIONAL BANC CORP's revenue compounded faster (6.2% CAGR vs -34.4%).

Farmers National Banc Corp (OH) is a regional financial holding company based in Ohio, the United States. It offers full-spectrum retail and commercial banking products, wealth management solutions, and insurance services, primarily catering to individual consumers, small and medium-sized enterprises, and local community clients in Ohio and adjacent Midwestern U.S. regions.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

FMNB vs MED — Head-to-Head

Bigger by revenue
MED
MED
1.1× larger
MED
$75.1M
$71.5M
FMNB
Growing faster (revenue YoY)
FMNB
FMNB
+40.1% gap
FMNB
3.2%
-36.9%
MED
More free cash flow
FMNB
FMNB
$58.8M more FCF
FMNB
$52.2M
$-6.6M
MED
Faster 2-yr revenue CAGR
FMNB
FMNB
Annualised
FMNB
6.2%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FMNB
FMNB
MED
MED
Revenue
$71.5M
$75.1M
Net Profit
$14.6M
Gross Margin
69.4%
Operating Margin
24.8%
-10.4%
Net Margin
20.5%
Revenue YoY
3.2%
-36.9%
Net Profit YoY
1.7%
EPS (diluted)
$0.39
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FMNB
FMNB
MED
MED
Q4 25
$71.5M
$75.1M
Q3 25
$70.8M
$89.4M
Q2 25
$69.8M
$105.6M
Q1 25
$67.8M
$115.7M
Q4 24
$69.3M
$119.0M
Q3 24
$70.3M
$140.2M
Q2 24
$66.5M
$168.6M
Q1 24
$63.4M
$174.7M
Net Profit
FMNB
FMNB
MED
MED
Q4 25
$14.6M
Q3 25
$12.5M
$-2.3M
Q2 25
$13.9M
$2.5M
Q1 25
$13.6M
$-772.0K
Q4 24
$14.4M
Q3 24
$8.5M
$1.1M
Q2 24
$11.8M
$-8.2M
Q1 24
$11.2M
$8.3M
Gross Margin
FMNB
FMNB
MED
MED
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
FMNB
FMNB
MED
MED
Q4 25
24.8%
-10.4%
Q3 25
20.7%
-4.6%
Q2 25
23.4%
-1.0%
Q1 25
24.1%
-1.1%
Q4 24
25.5%
0.6%
Q3 24
14.4%
1.5%
Q2 24
21.3%
-4.7%
Q1 24
21.2%
4.5%
Net Margin
FMNB
FMNB
MED
MED
Q4 25
20.5%
Q3 25
17.6%
-2.5%
Q2 25
19.9%
2.3%
Q1 25
20.0%
-0.7%
Q4 24
20.8%
Q3 24
12.1%
0.8%
Q2 24
17.7%
-4.8%
Q1 24
17.7%
4.8%
EPS (diluted)
FMNB
FMNB
MED
MED
Q4 25
$0.39
$-1.64
Q3 25
$0.33
$-0.21
Q2 25
$0.37
$0.22
Q1 25
$0.36
$-0.07
Q4 24
$0.38
$0.08
Q3 24
$0.23
$0.10
Q2 24
$0.31
$-0.75
Q1 24
$0.30
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FMNB
FMNB
MED
MED
Cash + ST InvestmentsLiquidity on hand
$167.3M
Total DebtLower is stronger
$86.7M
Stockholders' EquityBook value
$485.7M
$198.9M
Total Assets
$5.2B
$248.0M
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FMNB
FMNB
MED
MED
Q4 25
$167.3M
Q3 25
$173.5M
Q2 25
$162.7M
Q1 25
$164.6M
Q4 24
$162.3M
Q3 24
$170.0M
Q2 24
$163.5M
Q1 24
$156.4M
Total Debt
FMNB
FMNB
MED
MED
Q4 25
$86.7M
Q3 25
$86.6M
Q2 25
$86.4M
Q1 25
$86.3M
Q4 24
$86.2M
Q3 24
$86.0M
Q2 24
$88.9M
Q1 24
$88.8M
Stockholders' Equity
FMNB
FMNB
MED
MED
Q4 25
$485.7M
$198.9M
Q3 25
$465.9M
$214.7M
Q2 25
$437.7M
$216.0M
Q1 25
$429.1M
$211.0M
Q4 24
$406.0M
$210.1M
Q3 24
$439.7M
$207.3M
Q2 24
$396.7M
$205.3M
Q1 24
$397.0M
$211.0M
Total Assets
FMNB
FMNB
MED
MED
Q4 25
$5.2B
$248.0M
Q3 25
$5.2B
$268.2M
Q2 25
$5.2B
$269.3M
Q1 25
$5.2B
$280.0M
Q4 24
$5.1B
$284.2M
Q3 24
$5.2B
$291.2M
Q2 24
$5.2B
$293.5M
Q1 24
$5.1B
$302.8M
Debt / Equity
FMNB
FMNB
MED
MED
Q4 25
0.18×
Q3 25
0.19×
Q2 25
0.20×
Q1 25
0.20×
Q4 24
0.21×
Q3 24
0.20×
Q2 24
0.22×
Q1 24
0.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FMNB
FMNB
MED
MED
Operating Cash FlowLast quarter
$60.0M
$-5.3M
Free Cash FlowOCF − Capex
$52.2M
$-6.6M
FCF MarginFCF / Revenue
73.0%
-8.8%
Capex IntensityCapex / Revenue
11.0%
1.8%
Cash ConversionOCF / Net Profit
4.10×
TTM Free Cash FlowTrailing 4 quarters
$85.8M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FMNB
FMNB
MED
MED
Q4 25
$60.0M
$-5.3M
Q3 25
$10.7M
$12.1M
Q2 25
$14.0M
$-3.4M
Q1 25
$15.7M
$3.4M
Q4 24
$66.6M
$-4.9M
Q3 24
$23.9M
$9.1M
Q2 24
$16.6M
$13.1M
Q1 24
$13.7M
$7.3M
Free Cash Flow
FMNB
FMNB
MED
MED
Q4 25
$52.2M
$-6.6M
Q3 25
$9.0M
$10.8M
Q2 25
$12.4M
$-4.8M
Q1 25
$12.2M
$1.9M
Q4 24
$54.9M
$-7.2M
Q3 24
$20.4M
$7.7M
Q2 24
$14.4M
$11.1M
Q1 24
$12.2M
$5.4M
FCF Margin
FMNB
FMNB
MED
MED
Q4 25
73.0%
-8.8%
Q3 25
12.8%
12.0%
Q2 25
17.8%
-4.5%
Q1 25
18.0%
1.6%
Q4 24
79.2%
-6.1%
Q3 24
29.1%
5.5%
Q2 24
21.6%
6.6%
Q1 24
19.2%
3.1%
Capex Intensity
FMNB
FMNB
MED
MED
Q4 25
11.0%
1.8%
Q3 25
2.4%
1.5%
Q2 25
2.3%
1.3%
Q1 25
5.2%
1.3%
Q4 24
16.9%
1.9%
Q3 24
4.9%
1.0%
Q2 24
3.3%
1.1%
Q1 24
2.4%
1.1%
Cash Conversion
FMNB
FMNB
MED
MED
Q4 25
4.10×
Q3 25
0.86×
Q2 25
1.01×
-1.36×
Q1 25
1.15×
Q4 24
4.63×
Q3 24
2.80×
8.04×
Q2 24
1.41×
Q1 24
1.22×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons